Open Government Portal

Found 1166 records

Briefing binder created for the Minister of National Defence on the occasion of his appearance before the Special Committee on …

Record Modified: Nov 19, 2020
Record Released: Nov 19, 2020
Publisher: National Defence
Formats: HTML
Keywords: CAF Assistance in LCTF CAF Support to the Whole of Government Victoria Class Submarines MEDINT PPE Hateful conduct in the CAF

Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, …

Record Modified: Nov 18, 2020
Record Released: Oct 2, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic Interim Order notice explanatory note importation sale and advertising of drugs a significant risk to health safety or the environment guidance document to import sell and advertise drugs and vaccines a new authorization pathway ...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Public Health Agency of Canada
Formats: HTML PDF
Keywords: checklist COVID-19 Ebola emerging infectious disease emergency management high consequence pathogens infectious disease laboratory response outbreak preparedness outbreak response public health laboratory SARS SARS-CoV-2 COVID-19 COVID-19 ...

Parents, caregivers and children across the country are facing new challenges as the COVID-19 pandemic affects our daily work …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Public Health Agency of Canada
Formats: HTML PDF
Keywords: COVID-19 Coronavirus parenting children

Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic Interim Order notice explanatory note importation sale and advertising of drugs a significant risk to health safety or the environment guidance document to import sell and advertise drugs and vaccines a new authorization pathway ...

Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic drug and vaccine authorizations authorize the drug or vaccine for sale potential benefits and risks of a drug or vaccine health care practitioners and consumers benefits of the product potential risks

The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices.

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic testing devices antigen testing devices minimum values of sensitivity for COVID-19 antigen testing devices

Under the Interim Order, manufacturers and importers must report medical device shortages related to COVID-19 to Health Canada. The …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic reporting medical device shortages Interim Order manufacturers and importers list of Medical Devices notification of Shortages

This guidance document presents the criteria for safety and effectiveness that apply to test swabs used for COVID-19 sampling. …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic testing devices test swabs sampling criteria for safety and effectiveness

Most PPE, including face shields, are Class I medical devices if they are manufactured, sold or represented for use for …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic notice to industry regulatory considerations for importing or selling face shields PPE Class I medical devices reducing the risk of or preventing the user from infection authorized for sale or import